Get the latest Sagimet Biosciences Inc. (0O2.F) stock news and headlines to help you in your trading and investing decisions.
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, ...
FAA data valid effective Jun 11 2026 - Jul 9 2026 (unless otherwise noted).
FAA data valid effective Jun 11 2026 - Jul 9 2026 (unless otherwise noted).
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results